In childhood B-cell non Hodgkin's lymphoma (B-NHL) and mature B-cell acute leukemia (B-AL) with CNS disease at diagnosis, patients with blasts in CSF are at higher risk of event

被引：0
作者：
Minard, V. [1 ]
Auperin, A. [1 ]
Leverger, G. [2 ]
Schmitt, C. [3 ]
Aladjidi, N. [4 ]
Michon, J. [5 ]
Patte, C. [1 ]
机构：
[1] IGR, Villejuif, France
[2] Hop Trousseau, F-75571 Paris, France
[3] Hop Enfants, Vandoeuvre Les Nancy, France
[4] Hop Enfants, Bordeaux, France
[5] Inst Curie, Paris, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [41] Radioimmunotherapy of B-cell non-Hodgkin's lymphoma
    Postema, EJ
    Boerman, OC
    Oyen, WJG
    Raemaekers, JMM
    Corstens, FHM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (11) : 1725 - 1735
  • [42] Radioimmunotherapy of B-cell non-Hodgkin's lymphoma
    Bodet-Milin, Caroline
    Ferrer, Ludovic
    Pallardy, Amandine
    Eugene, Thomas
    Rauscher, Aurore
    Faivre-Chauvet, Alain
    Barbet, Jacques
    Kraeber-Bodere, Francoise
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [43] Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL)
    J. Braess
    K. Reich
    S. Willert
    F. Strutz
    C. Neumann
    W. Hiddemann
    B. Wörmann
    Annals of Hematology, 1997, 75 : 227 - 230
  • [44] Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL)
    Braess, J
    Reich, K
    Willert, S
    Strutz, F
    Neumann, C
    Hiddemann, W
    Wörmann, B
    ANNALS OF HEMATOLOGY, 1997, 75 (5-6) : 227 - 230
  • [45] Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis
    Hua, Qingling
    Zhu, Yanzhe
    Liu, Hu
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (06) : 365 - 370
  • [46] MACHO CHEMOTHERAPY FOR STAGE-IV B-CELL LYMPHOMA AND B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA OF CHILDHOOD
    HANN, IM
    EDEN, OB
    BARNES, J
    PINKERTON, CR
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (03) : 359 - 364
  • [47] Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children
    Minard-Colin, Veronique
    Auperin, Anne
    Pillon, Marta
    Burke, G. A. Amos
    Barkauskas, Donald A.
    Wheatley, Keith
    Delgado, Rafael F.
    Alexander, Sarah
    Uyttebroeck, Anne
    Bollard, Catherine M.
    Zsiros, Jozsef
    Csoka, Monika
    Kazanowska, Bernarda
    Chiang, Alan K.
    Miles, Rodney R.
    Wotherspoon, Andrew
    Adamson, Peter C.
    Vassal, Gilles
    Patte, Catherine
    Gross, Thomas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (23) : 2207 - 2219
  • [48] A study of rituximab and ifosfamide, carboplatin, etoposide (ICE) chemotherapy in children with recurrent/refractory B-cell non-Hodgkin lymphoma (NHL) and mature B-cell acute lymphoblastic leukemia (B-ALL). A children's oncology group report
    Griffin, T.
    Weitzman, S.
    Weinstein, H.
    Chang, M.
    Hutchison, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 109 - 109
  • [49] Prognostic significance of extranodal involvement in B-cell non-Hodgkin's lymphoma (NHL).
    Reiser, M
    Skavron, R
    Elter, T
    Pfistner, B
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 263B - 263B
  • [50] Venous Thromboembolism in Patients with B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Lenalidomide
    Yamshon, Samuel
    Demetres, Michelle
    Hammad, Hoda
    Christos, Paul J.
    Leonard, John P.
    Ruan, Jia
    BLOOD, 2017, 130
12345